WO2004060381A8 - Rabbit skin comprising biological active substance and its use - Google Patents
Rabbit skin comprising biological active substance and its useInfo
- Publication number
- WO2004060381A8 WO2004060381A8 PCT/CN2003/000923 CN0300923W WO2004060381A8 WO 2004060381 A8 WO2004060381 A8 WO 2004060381A8 CN 0300923 W CN0300923 W CN 0300923W WO 2004060381 A8 WO2004060381 A8 WO 2004060381A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- active substance
- biological active
- rabbit skin
- rabbits
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/10—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from hair, feathers, horn, skins, leather, bones, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ540428A NZ540428A (en) | 2002-10-31 | 2003-10-30 | Rabbit skin comprising biological active substance and its use |
EP03770855A EP1557171A4 (en) | 2002-10-31 | 2003-10-30 | RABBIT WITH A BIOLOGICAL ACTIVE SUBSTANCE AND ITS USE |
AU2003280918A AU2003280918A1 (en) | 2002-10-31 | 2003-10-30 | Rabbit skin comprising biological active substance and its use |
US10/532,687 US20060051375A1 (en) | 2002-10-31 | 2003-10-30 | Rabbit skin comprising biological active substances and its use |
US12/880,856 US20110003009A1 (en) | 2002-10-31 | 2010-09-13 | Process for obtaining a rabbit skin comprising biological active substances |
US13/777,637 US8900639B2 (en) | 2002-10-31 | 2013-02-26 | Process for obtaining a rabbit skin comprising biological active substances |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021459754A CN1207005C (zh) | 2002-10-31 | 2002-10-31 | 含生物活性物质的兔皮和其用途 |
CN02145975.4 | 2002-10-31 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10532687 A-371-Of-International | 2003-10-30 | ||
US12/880,856 Continuation US20110003009A1 (en) | 2002-10-31 | 2010-09-13 | Process for obtaining a rabbit skin comprising biological active substances |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004060381A1 WO2004060381A1 (fr) | 2004-07-22 |
WO2004060381A8 true WO2004060381A8 (en) | 2006-08-10 |
Family
ID=32686811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2003/000923 WO2004060381A1 (fr) | 2002-10-31 | 2003-10-30 | Peau de lapin comprenant une substance bioactive et son utilisation |
Country Status (7)
Country | Link |
---|---|
US (3) | US20060051375A1 (zh) |
EP (1) | EP1557171A4 (zh) |
KR (2) | KR20050072768A (zh) |
CN (1) | CN1207005C (zh) |
AU (1) | AU2003280918A1 (zh) |
NZ (1) | NZ540428A (zh) |
WO (1) | WO2004060381A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003280684B2 (en) * | 2002-10-31 | 2009-06-25 | Nippon Zoki Pharmaceutical Co., Ltd. | Remedy for fibromyalgia |
CN1207005C (zh) | 2002-10-31 | 2005-06-22 | 威世药业(如皋)有限公司 | 含生物活性物质的兔皮和其用途 |
KR101307999B1 (ko) * | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
CN1613305B (zh) * | 2004-12-06 | 2011-01-12 | 威世药业(如皋)有限公司 | 一种从含新型活性物质的兔皮中提取的活性制剂 |
CN101732348B (zh) * | 2008-11-11 | 2015-01-14 | 威世药业(如皋)有限公司 | 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途 |
US9422336B2 (en) | 2012-05-25 | 2016-08-23 | Well Resources Limited | Peptide for treatment of disease or symptoms associated with pain |
CN103357006B (zh) | 2012-10-10 | 2014-10-15 | 日本脏器制药株式会社 | 含有提取物的制剂的检查方法 |
JP5490939B2 (ja) * | 2013-04-19 | 2014-05-14 | 日本臓器製薬株式会社 | 抽出物及び製剤 |
TWI737229B (zh) | 2013-04-30 | 2021-08-21 | 日商日本臟器製藥股份有限公司 | 製劑的製造方法、製劑製造的管理方法及製劑的檢查方法 |
KR20180108903A (ko) * | 2015-05-29 | 2018-10-04 | 니폰 조키 세야쿠 가부시키가이샤 | 다능성 간세포 유주 촉진제 |
WO2017146230A1 (ja) * | 2016-02-24 | 2017-08-31 | 国立大学法人大阪大学 | 試験方法 |
CN105663166B (zh) * | 2016-03-02 | 2020-04-17 | 中国人民解放军疾病预防控制所 | 特异性抗天花病毒感染模型毒株的生物活性制剂及应用 |
CN109512838B (zh) * | 2017-09-15 | 2022-05-10 | 天津小西生物医药科技有限公司 | 一种兔皮提取物及其制备方法和用途 |
CN113747904A (zh) | 2019-04-17 | 2021-12-03 | 诺希生物药物开发有限公司 | 痘苗病毒致炎兔皮提取物治疗造血系统损伤的用途 |
EP3984543A4 (en) | 2019-06-14 | 2023-01-25 | Mega Winning Limited | USE OF AN EXTRACT FROM VACCINIA VIRUS INFLAMMATED RABBIT SKIN TO TREAT CANCER |
RU2707948C1 (ru) * | 2019-09-02 | 2019-12-02 | Виктор Александрович Сисев | Фармацевтическая композиция для парентерального капельного введения (варианты) |
CN111904981A (zh) * | 2020-09-07 | 2020-11-10 | 威世药业(如皋)有限公司 | 一种痘苗病毒致炎兔皮生产方法 |
CN111944042A (zh) * | 2020-09-07 | 2020-11-17 | 威世药业(如皋)有限公司 | 一种蛋白-a抗原的制备工艺 |
CN111956669A (zh) * | 2020-09-07 | 2020-11-20 | 威世药业(如皋)有限公司 | 一种牛痘疫苗致炎兔皮提取物注射液制造工艺 |
CN115212235A (zh) * | 2022-07-25 | 2022-10-21 | 威世药业(如皋)有限公司 | 一种稀释后痘苗病毒致炎兔皮生产方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3455784A (en) * | 1966-03-11 | 1969-07-15 | American Home Prod | Control of enzyme activity in frozen systems |
US3949073A (en) * | 1974-11-18 | 1976-04-06 | The Board Of Trustees Of Leland Stanford Junior University | Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution |
JPS53101515A (en) | 1977-02-17 | 1978-09-05 | Nippon Zoki Pharmaceutical Co | Medicine having anodyne * sedative and antiallergic activity and production thereof |
JPS578741A (en) * | 1980-06-17 | 1982-01-18 | Eisai Co Ltd | Quality improvement of animal fur |
FR2564320B1 (fr) | 1984-05-18 | 1986-10-17 | Pasteur Institut | Procede de production de vaccin antirabique sur des cultures de lignees de cellules non tumorigenes de lapin, vaccin antirabique obtenu par ce procede et nouvelles lignees cellulaires utilisables pour la production dudit vaccin |
JPS6339572A (ja) * | 1986-08-05 | 1988-02-20 | 株式会社チノー | 葉たばこ乾燥装置 |
US4798171A (en) * | 1987-07-09 | 1989-01-17 | Nu Aire, Inc. | Animal isolator |
JP2651674B2 (ja) * | 1987-07-23 | 1997-09-10 | 日本臓器製薬 株式会社 | 新規生理活性物質及びその製造方法 |
US4985254A (en) * | 1987-11-06 | 1991-01-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Method of treating ischemic diseases |
EP0341209B1 (en) * | 1988-04-30 | 1993-09-15 | Nippon Zoki Pharmaceutical Co. Ltd. | Physiologically active substances, a process for preparation and pharmaceutical compositions thereof |
JP2539665B2 (ja) * | 1988-06-20 | 1996-10-02 | 日本臓器製薬株式会社 | 神経疾患治療剤 |
US5225331A (en) * | 1991-04-25 | 1993-07-06 | National Research Council Of Canada | Immunoassay for detecting group b streptococcus |
JP2594222B2 (ja) | 1993-09-28 | 1997-03-26 | 日本臓器製薬株式会社 | 新規生理活性物質−kf |
US6019988A (en) * | 1996-11-18 | 2000-02-01 | Bristol-Myers Squibb Company | Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage |
JP4033936B2 (ja) * | 1997-01-08 | 2008-01-16 | 日本臓器製薬株式会社 | 一酸化窒素産生抑制剤 |
JPH1180005A (ja) * | 1997-09-12 | 1999-03-23 | Nippon Zoki Pharmaceut Co Ltd | 骨粗鬆症治療剤 |
JPH11139977A (ja) * | 1997-11-07 | 1999-05-25 | Nippon Zoki Pharmaceut Co Ltd | Nef作用抑制剤 |
US5960635A (en) * | 1998-03-03 | 1999-10-05 | Dakhil; Farouk | Air conditioning apparatus using liquid nitrogen |
CA2270050A1 (en) * | 1998-04-27 | 1999-10-27 | Jin-Emon Konishi | A therapeutic agent for ischemic diseases |
CN100425692C (zh) | 1998-06-02 | 2008-10-15 | 株式会社富吉摩托普拉泽兹 | 含有高质量生理活性的家兔发痘组织的制造方法 |
CN1055249C (zh) | 1998-07-15 | 2000-08-09 | 沈继平 | 一种镇痛药和其制造方法 |
KR20000076874A (ko) * | 1999-03-19 | 2000-12-26 | 고니시 진우에몬 | 케모카인 생산 촉진제 |
JP4612924B2 (ja) * | 1999-08-20 | 2011-01-12 | 藤本製薬株式会社 | サイトカイン調節剤 |
JP2001058949A (ja) * | 1999-08-20 | 2001-03-06 | Fujimoto Brothers:Kk | 抗ショック剤 |
NZ533302A (en) * | 2001-12-10 | 2005-11-25 | Bavarian Nordic As | Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions containing a disaaccharide and a pharmaceutically acceptable polymer i.e. dextran or polyvinylpyrrolidon (PVP) |
CN1207005C (zh) | 2002-10-31 | 2005-06-22 | 威世药业(如皋)有限公司 | 含生物活性物质的兔皮和其用途 |
-
2002
- 2002-10-31 CN CNB021459754A patent/CN1207005C/zh not_active Ceased
-
2003
- 2003-10-30 US US10/532,687 patent/US20060051375A1/en not_active Abandoned
- 2003-10-30 WO PCT/CN2003/000923 patent/WO2004060381A1/zh not_active Application Discontinuation
- 2003-10-30 EP EP03770855A patent/EP1557171A4/en not_active Ceased
- 2003-10-30 KR KR1020057006991A patent/KR20050072768A/ko active Search and Examination
- 2003-10-30 KR KR1020087008934A patent/KR20080048536A/ko active Search and Examination
- 2003-10-30 AU AU2003280918A patent/AU2003280918A1/en not_active Abandoned
- 2003-10-30 NZ NZ540428A patent/NZ540428A/en not_active IP Right Cessation
-
2010
- 2010-09-13 US US12/880,856 patent/US20110003009A1/en not_active Abandoned
-
2013
- 2013-02-26 US US13/777,637 patent/US8900639B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1557171A4 (en) | 2006-08-09 |
KR20080048536A (ko) | 2008-06-02 |
KR20050072768A (ko) | 2005-07-12 |
US20130183386A1 (en) | 2013-07-18 |
US8900639B2 (en) | 2014-12-02 |
AU2003280918A8 (en) | 2004-07-29 |
US20110003009A1 (en) | 2011-01-06 |
EP1557171A1 (en) | 2005-07-27 |
AU2003280918A1 (en) | 2004-07-29 |
CN1493302A (zh) | 2004-05-05 |
CN1207005C (zh) | 2005-06-22 |
US20060051375A1 (en) | 2006-03-09 |
WO2004060381A1 (fr) | 2004-07-22 |
NZ540428A (en) | 2007-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004060381A8 (en) | Rabbit skin comprising biological active substance and its use | |
WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
WO2004110472A3 (en) | Fusion proteins | |
ATE430558T1 (de) | Herstellung von mikrokügelchen | |
NZ709704A (en) | Protein formulations and methods of making same | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
AU2003228442A1 (en) | Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives | |
GB0211649D0 (en) | Organic compounds | |
IL173369A (en) | Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells | |
WO2008137780A3 (en) | Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases | |
BRPI0414215A (pt) | tienopirazóis | |
AU2003229284A1 (en) | Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur | |
WO2003031407A3 (en) | β-LACTAMYL VASOPRESSIN VlaANTAGONISTS | |
AU2003207417A1 (en) | Use of tryptophan rich peptides | |
EA200400399A1 (ru) | Способы лечения легочных заболеваний | |
WO2007025229A3 (en) | Compositions and their uses directed to hsp27 | |
WO2004054557A3 (en) | Treatment of mastalgia with 4-hydroxy tamoxifen | |
WO2003039591A3 (de) | Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle | |
WO2001088137A3 (en) | Human myd88 adapter-like protein and functional fragments thereof | |
WO2001054707A3 (de) | Veränderung von oberflächenproteomem durch aminopeptidase-inhibitoren | |
WO2001045743A3 (de) | Verwendung eines enzyms zur verbesserung der geweberesorption von arzneimitteln | |
WO2003080657A3 (en) | Yeast pheromones for the treatment of infectious diseases | |
DE60327249D1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung | |
BR0316059A (pt) | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise | |
WO2003101387A3 (en) | Globulin protein to lower cholesterol in humans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1200500378 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003770855 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 306/MUMNP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057006991 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2005-500764 Country of ref document: PH |
|
ENP | Entry into the national phase |
Ref document number: 2006051375 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10532687 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 540428 Country of ref document: NZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057006991 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003770855 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10532687 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |